(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MOBIDIAG

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MOBIDIAG

ST13

US500000087764322

Class

1, 5, 9, 10

Filing

87764322

Registration

6144542

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

09/09/2025

Trademark type

Combined

Nice classes

1, 5, 9, 10

Filing date

01/22/2018

Registration date

09/08/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/08/2020

Last transaction

09/09/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

5

Owner type

99

Owner location

ESPOO, FI

Examiner

PEISECKI, MARK

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized letters "MOBIDIAG" with the letters "MOBI" in light blue and "DIAG" in grey.

Holders and representatives

Holders

Mobidiag Oy

Representatives

Charles F. Reidelbach, Jr., Esq. HIGGS FLETCHER & MACK LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents for scientific and research use; Reagentsother than for medical usefor sale in kit form and comprising of reagents for detecting nucleic acids or other biological markers; Reagents for in-vitro useother than for medical purposes; Diagnostic preparations and reagents for scientific and research usefor in- vitro useother than medical use; chemical tests for scientific and research use for detecting nucleic acids or other biological markers; chemical testsother than for medical use for sale in kit form for detecting nucleic acids or other biological markers; chemical tests for in-vitro useother than for medical usefor detecting nucleic acids or other biological markers

Class 5

Pharmaceutical and veterinary preparations for detecting nucleic acids or other biological markers from animals or their microbes; sanitary preparations for medical purposes; Medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic kits comprised of medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic reagents for the extractionamplificationpurification of nucleic acids; clinical medical reagents and assays for the extraction amplificationpurification of nucleic acids

Class 9

Computer hardware and software for scientificindustrial and medical analysis and research purposescomputer hardware and recorded software for use in in-vitro diagnostics and for detecting nucleic acids or other biological markersin particular for the diagnosis of medical conditions in humans and animals; laboratory robots

Class 10

Surgicalmedicaldental and veterinary equipment and instruments for clinical diagnosis purposeslaboratory equipment for use in in-vitro diagnostics or for detecting nucleic acids or other biological markersin particular for detecting infectious diseasesfor medical purposes

Publications

History of USPTO decisions and trademark events.

36 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/13/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/13/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/13/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/13/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/08/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/23/2020

PUBO

PUBLISHED FOR OPPOSITION

06/23/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/03/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/15/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

05/15/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/15/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

05/15/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/15/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/08/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/08/2019

GNRT

NON-FINAL ACTION E-MAILED

11/08/2019

CNRT

NON-FINAL ACTION WRITTEN

11/08/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/15/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/15/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/15/2019

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

02/19/2019

GPRA

PRIORITY ACTION E-MAILED

02/19/2019

CPRA

PRIORITY ACTION WRITTEN

02/19/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/19/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/19/2018

ALIE

ASSIGNED TO LIE

11/19/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/06/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/08/2018

GNRT

NON-FINAL ACTION E-MAILED

05/08/2018

CNRT

NON-FINAL ACTION WRITTEN

05/08/2018

DOCK

ASSIGNED TO EXAMINER

05/02/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/01/2018

NWAP

NEW APPLICATION ENTERED

01/25/2018

Continuous trademark protection

Get notified about every new filing that threatens MOBIDIAG or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.